Biomedical Engineering Reference
In-Depth Information
37. Takashima A, Morita A. Genomic, phenotypic, and functional analyses of T cells in
patients with psoriasis undergoing systemic cyclosporin A treatment. J. Invest. Dermatol.
1991;96:376-382.
38. Khoury JS, Guttmann RGC, Orav EJ, Kikinis R, Jolesz AF, Weiner LH. Changes in
activated T cells in the blood correlate with disease activity in multiple sclerosis. Arch.
Neurol. 2000;57:1183-1189.
39. Strauss K, Hulstaert F, Deneys V, Mazzon AM, Hannet I, De BruyereM, Reichert T, Sindic
CJ. The immune profile of multiple sclerosis: T-lymphocyte effects predominate over all
other
factors in cyclophosphamide-treated patients. J. Neuro.
Immunol. 1995;63
(2):133-142.
40. McLaughlin BE, Baumgarth N, Bigos M, Roederer M, Rosa CS, Altman JD, Nixon DF,
Ottinger J, Oxford C, Evans TG, Asmuth DM. Nine-color flow cytometry for accurate
measurement of T cell subsets and cytokine responses. Part I: Panel design by an empiric
approach. Cytometry A 2008;73:400.
41. McLaughlin BE, Baumgarth N, Bigos M, Roederer M, Rosa CS, Altman JD, Nixon DF,
Ottinger J, Li J, Beckett L, Shacklett BL, Evans TG, Asmuth DM. Nine-color flow
cytometry for accurate measurement of T cell subsets and cytokine responses. Part II:
Panel performance across different instrument platforms. Cytometry A 2008;73:411.
42. Mahnke YD, Roederer M. Optimizing a multi-colour immunophenotping assay. Clin. Lab.
Med. 2007;27(3);469 -v.
43. Streck News, Release. Streck Blood Collection Tube Cleared by FDA. Streck Inc., Omaha,
NE, 2008.
44. WarrinoDE, DeGennaro LJ, HansonM, Swindells S, Pirruccello SJ, RyanW. Stabilization
of WBCs and immunologic markers for extended analysis using flow cytometry. J.
Immunol. Methods 2005;305:107-119.
45. Weinberg A, Song LY, Wilkening C, Sevin A, Blais B, Louzao R, Stein D, Defechereuz P,
Durand D, Reidel E, Raftery N, Jesser R, Brown B, Keller MF, Dickover R, McFarland E,
Fenton T. Optimization and limitations of use of cryopreserved peripheral blood
mononuclear cells for functional and phenotypic T-cell characterization. Clin. Vaccine
Immunol. 2009;16(8):1176-1186.
46. Bull M, Lee D, Stucky J, Chiu Y-L, Rubin A, Horton H, McElrath MJ. Defining blood
processing parameters for optimal detection of cryopreserved antigen-specific responses
for HIV vaccine trials. J. Immunol. Methods 2007;322:57-69.
47. Reimann KA, Chernoff M, Wilkening CL, Nickerson CE, Landay AL, and ACTG
Immunology Advanced Technology Laboratories. Preservation of lymphocyte
immunophenotype and proliferative responses in cryopreserved peripheral blood
mononuclear cells from human immunodeficiency virus type 1-infected donors:
implications for multicenter clinical trials. Clin. Diagn. Lab. Immunol. 2000;7(3):352-359.
48. Owen RE, Sinclair E, Emu B, Heitman JW, Hirschkorn DF, Eplng CL, Tan QX, Custer B,
Harris JM, JacobsonMA, McCune JM,Martin JN, Hecht FM, Deeks SG, Norris PJ. Loss of
T cell
responses
following long-term cryopreservation. J.
Immunol. Methods
2007;326:93-115.
49. Maecker HT, Trotter J. Flow cytometry controls, instrument setup and the determinations
of positivity. Cytometry A 2006;69A:1037-1042.
50. Wang L, Gaigalas AK, Marti G, Abbasi F, Hoffman RA. Toward quantitative fluorescence
measurements with multicolor flow cytometry. Cytometry A 2008;73:279.
Search WWH ::
Custom Search